About Cephea Valve Technologies
Cephea Valve Technologies is a Healthcare company based in Santa Clara (United States) founded in 2013, and was acquired by Abbott in January 2019. Catheter-delivered mitral valves are developed with non-stent anchoring technology. Cephea Valve Technologies has raised $14.71 million across 1 funding round from investors including Abbott. The company was acqui-hired. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its competitors include Shockwave Medical, Cardiac Dimensions and JenaValve Technology; 3 of its 3 listed competitors have raised funding.
Company details
Cephea Valve Technologies was founded in 2013 and is based in Santa Clara, United States. The company operates in the medical device sector, focusing on cardiovascular innovations. A catheter-delivered mitral valve is being developed, utilizing non-stent-based anchoring for placement. The valve is intended to be inserted into the heart through a catheter threaded via the femoral vein, addressing mitral valve regurgitation in patients.
- Headquarters Santa Clara, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website cephea.com
- Social LinkedIn
- Acquired by Abbott (Jan 2019)
Funding Insights of Cephea Valve Technologies
Cephea Valve Technologies has successfully raised a total of $14.71M through 1 strategic funding round. The most recent funding activity was a Series B round of $14.71 million completed in January 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $14.71M
- Total Rounds 1
- Last Round Series B — $14.71M
- First Round $14.71M
(Jan 2015)
All 1 funding rounds of Cephea Valve Technologies with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2015 | $14.71M | Series B | – | – | – |
1 investors in total: 1 institutional.
Investors in Cephea Valve Technologies
Cephea Valve Technologies has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Abbott.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | abbott.com | Libertyville, United States |
Investor details for Cephea Valve Technologies
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Cephea Valve Technologies
3 dated milestones of Cephea Valve Technologies across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Cephea Valve Technologies is founded.
- Funding First funding round of $14.7M.
- Exit Acquired by Abbott.
Competitors of Cephea Valve Technologies
Cephea Valve Technologies has 3 listed competitors in our database, 3 of them funded. They include Shockwave Medical, Cardiac Dimensions and JenaValve Technology.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| shockwavemedical.com | 2009 | Santa Clara, United States | $147.5M | 1,394 | Cardiovascular balloon dilation catheters with lithotripsy electrodes are developed. | |
| cardiacdimensions.com | 2001 | Kirkland, United States | $260.8M | 31 | Invasive cardiac implants for heart failure treatment are developed. | |
| jenavalve.com | 2006 | Irvine, United States | $363.7M | 198 | Pericardial transcatheter aortic valve replacement systems are provided. |
Detailed competitors of Cephea Valve Technologies
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Cardiac and Vascular Disorders
3 companies that operate in the same segment as Cephea Valve Technologies (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | 255 | ||
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cephea Valve Technologies
Complete news archive for Cephea Valve Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cephea Valve Technologies
Cephea Valve Technologies was founded in 2013 and raised its 1st funding round 2 years after it was founded.
Cephea Valve Technologies is headquartered in Santa Clara, United States. It is registered at Santa Clara, California, United States.
Cephea Valve Technologies is a funded company, having raised a total of $14.71M across 1 funding round to date. The company's 1st funding round was a Series B of $14.71M, raised on Jan 2015.
Cephea Valve Technologies was founded in 2013 and is based in Santa Clara, United States. The company operates in the medical device sector, focusing on cardiovascular innovations. A catheter-delivered mitral valve is being developed, utilizing non-stent-based anchoring for placement. The valve is intended to be inserted into the heart through a catheter threaded via the femoral vein, addressing mitral valve regurgitation in patients.
Cephea Valve Technologies's top competitors include Shockwave Medical, Cardiac Dimensions and JenaValve Technology.
Cephea Valve Technologies has 1 investor. Key investors include Abbott.
Yes. Cephea Valve Technologies was acquired by Abbott in January 2019.